Enovis - 17 Year Stock Price History | ENOV
Historical daily share price chart and data for Enovis since 2008 adjusted for splits and dividends. The latest closing stock price for Enovis as of May 30, 2025 is 31.30.
- The all-time high Enovis stock closing price was 128.86 on July 01, 2014.
- The Enovis 52-week high stock price is 51.00, which is 62.9% above the current share price.
- The Enovis 52-week low stock price is 29.32, which is 6.3% below the current share price.
- The average Enovis stock price for the last 52 weeks is 42.15.
| Enovis Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 38.8587 | 44.3000 | 47.9900 | 30.6600 | 31.3000 | -28.67% |
| 2024 | 49.9288 | 55.4400 | 63.8000 | 38.7200 | 43.8800 | -21.67% |
| 2023 | 55.7392 | 54.4000 | 65.9200 | 43.6700 | 56.0200 | 4.67% |
| 2022 | 60.2850 | 79.8728 | 80.7843 | 44.8300 | 53.5200 | -32.31% |
| 2021 | 78.4859 | 63.7400 | 91.1038 | 63.7400 | 79.0644 | 20.21% |
| 2020 | 53.1074 | 63.6540 | 66.9046 | 25.1795 | 65.7695 | 5.11% |
| 2019 | 48.9639 | 35.9634 | 62.7081 | 34.7251 | 62.5705 | 74.07% |
| 2018 | 54.7331 | 68.4870 | 71.8236 | 33.0223 | 35.9462 | -47.25% |
| 2017 | 67.9065 | 63.4648 | 74.2315 | 59.9906 | 68.1430 | 10.27% |
| 2016 | 50.2422 | 40.8307 | 68.3666 | 33.1771 | 61.7965 | 53.88% |
| 2015 | 69.9124 | 89.6763 | 91.9638 | 37.8381 | 40.1600 | -54.72% |
| 2014 | 110.4694 | 108.6810 | 128.8560 | 81.1799 | 88.6959 | -19.03% |
| 2013 | 87.5806 | 72.2192 | 109.5410 | 69.5533 | 109.5410 | 57.84% |
| 2012 | 56.9873 | 48.5876 | 69.3985 | 42.6539 | 69.3985 | 41.68% |
| 2011 | 40.1237 | 32.2484 | 54.6932 | 31.2508 | 48.9831 | 54.70% |
| 2010 | 22.9512 | 21.2925 | 32.5064 | 17.6463 | 31.6636 | 52.91% |
| 2009 | 16.6750 | 18.5063 | 23.4424 | 9.3047 | 20.7078 | 15.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.788B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.506B | 58.15 |
| Hims & Hers Health (HIMS) | United States | $12.660B | 131.53 |
| Tempus AI (TEM) | United States | $9.553B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.485B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.076B | 63.69 |
| Privia Health (PRVA) | United States | $2.775B | 189.67 |
| Clover Health Investments (CLOV) | United States | $1.598B | 0.00 |
| Schrodinger (SDGR) | United States | $1.586B | 0.00 |
| Phreesia (PHR) | United States | $1.457B | 0.00 |
| Omnicell (OMCL) | United States | $1.423B | 25.10 |
| Azenta (AZTA) | United States | $1.223B | 56.85 |
| 10x Genomics (TXG) | United States | $1.173B | 0.00 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.593B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 159.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.384B | 0.00 |
| TruBridge (TBRG) | United States | $0.360B | 797.67 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |